M olecular oxygen can undergo a series of consecutive oneelectron reduction steps, forming the intermediates superoxide, hydrogen peroxide and hydroxyl anion before complete reduction to water. These intermediates are collectively called reactive oxygen species (ROS). ROS damage various cellular components such as lipids, proteins and DNA, and are implicated in cancer, cardiovascular disease, neurodegenerative disorders and aging [1][2] [3] [4] . In particular, superoxide is produced during aerobic metabolism in mitochondria and prokaryotes. All cells living in aerobic habitats contain soluble superoxide dismutase (SOD) enzymes disproportionating superoxide to molecular oxygen and hydrogen peroxide, which is in turn detoxified by catalases or peroxidases. SODs make up the most common biochemical defense against superoxide 5, 6 , whereas in some anaerobic organisms, an enzyme reducing superoxide to hydrogen peroxide has also been identified 7 . Remarkably, these hydrogen peroxide-generating mechanisms remain the only identified protection against superoxide in biology.
M olecular oxygen can undergo a series of consecutive oneelectron reduction steps, forming the intermediates superoxide, hydrogen peroxide and hydroxyl anion before complete reduction to water. These intermediates are collectively called reactive oxygen species (ROS). ROS damage various cellular components such as lipids, proteins and DNA, and are implicated in cancer, cardiovascular disease, neurodegenerative disorders and aging [1] [2] [3] [4] . In particular, superoxide is produced during aerobic metabolism in mitochondria and prokaryotes. All cells living in aerobic habitats contain soluble superoxide dismutase (SOD) enzymes disproportionating superoxide to molecular oxygen and hydrogen peroxide, which is in turn detoxified by catalases or peroxidases. SODs make up the most common biochemical defense against superoxide 5, 6 , whereas in some anaerobic organisms, an enzyme reducing superoxide to hydrogen peroxide has also been identified 7 .
Remarkably, these hydrogen peroxide-generating mechanisms remain the only identified protection against superoxide in biology.
In eukaryotic systems, superoxide is also actively produced by the immune system as a bactericide 8 , and an additional role as second messenger in intracellular signaling has been proposed 9 . A major source for ROS are the redox centers of respiratory chain enzymes that generate and maintain the electrochemical gradient during oxidative phosphorylation in mitochondria and many bacteria 10, 11 . The quinone pool acts as the central hub for shuttling electrons between different respiratory proteins. In Escherichia coli, for example, NDH-2 (a non-proton pumping NADH:quinone oxidoreductase) is a major contributor to both reduced quinone and superoxide 11, 12 . In contrast to neutral oxygen, which is enriched in membranes 13 , superoxide is negatively charged and less soluble in the hydrophobic core of membranes 14 . Most superoxide is produced by flavin redox groups in the cytoplasm and quenched by SOD 15 ; however, superoxide production at intramembranous sites has been reported for complex II and III enzymes and illuminated thylakoid membranes [16] [17] [18] . Moreover, release of superoxide into the periplasm via menaquinone autooxidation in the cytoplasmic membrane has also been discussed 19 . In 1982, E. coli cytochrome b 561 (cybB) was cloned 20, 21 and determined to encode an integral membrane protein containing two b-type hemes. In vivo experiments showed that the protein is reduced by d-lactate, suggesting that CybB is involved in the respiratory chain. It was also predicted that CybB may react with quinones (due to its measured midpoint potential of + 20 mV) [20] [21] [22] . To date, the natural electron donor of CybB has not been discovered, and its biological role remains unknown 20 .
Here we show that CybB from E. coli functions as a superoxide:ubiquinone oxidoreductase, performing a previously undescribed enzymatic reaction in which superoxide is directly oxidized to molecular oxygen and the sequestered electron is funneled to ubiquinone. The protein thus functions as a superoxide oxidase (SOO). Using in vitro experiments, we unravel the electron transport process from superoxide to ubiquinone. Furthermore, we show that liposome embedded CybB efficiently reacts with superoxide generated at the membrane and reduces the amount of superoxide produced by respiring membranes. We also present the 2.0 Å crystal structure of CybB, showing an integral membrane di-heme cytochrome poised for electron transfer from the P-side to the N-side and proton uptake from the N-side. This arrangement suggests a possible mechanism in which superoxide quenching contributes to the generation of electrochemical potential, while avoiding generation of other ROS such as hydrogen peroxide. In contrast to soluble SODs, the membrane-bound CybB may be optimized for quenching superoxide produced in the membrane or at its surface. spectrum of oxidized (ferric) heme b that is fully reduced to the ferrous state by dithionite ( Fig. 1a and Supplementary Fig. 1 ), which has been reported previously 20 . CybB reacted with ubiquinol Q 2 H 2 , displaying a ~50% reduction of CybB compared to dithionite (Fig. 1a,b) . d-lactate alone, however, did not reduce purified CybB (as observed in vivo 21 ). Also, other cellular reductants such as NADH, succinate, glutathione and ascorbate were only able to marginally reduce CybB after prolonged incubation (Fig. 1b) . However, if NADH was combined with the monotopic membrane protein NADH:quinone oxidoreductase NDH-2 (ref. 23 ), full reduction of CybB was observed in the presence of ubiquinone Q 2 (Fig. 1b and Supplementary Fig. 2 ). Interestingly, a ~50% reduction of CybB was also observed in the absence of ubiquinone Q 2 , suggesting an additional quinone-independent reduction mechanism. Kinetic analysis showed that both the quinone-dependent and independent reactions are fast processes with τ 1/2 < 50 ms ( Supplementary  Fig. 3 ), which is similar to the kinetics of other heme-containing enzymes 24 . Surprisingly, the quinone-independent reaction did not occur under anaerobic conditions (Fig. 1c) , indicating a mechanism via an intermediate oxygen-derived species. In concordance with this, the presence of SOD -but not catalase -abolished reduction of detergent-solubilized CybB by NADH and NDH-2. This data indicates that the superoxide anion (O 2
•−
), but not hydrogen peroxide (H 2 O 2 ) is the CybB-reducing species. This was further corroborated by the result that H 2 O 2 was unable to reduce CybB directly (Fig. 1c) . To unambiguously determine whether superoxide is indeed the CybB-reducing species, hypoxanthine (HPX) and xanthine oxidase (XO) -a prototypical superoxide-producing system -was utilized. CybB was reduced under aerobic conditions (~50%), but not under anaerobic conditions or in the presence of SOD (Fig. 1d ). In contrast, CybB reduction via ubiquinol Q 2 H 2 was not dependent on oxygen and remained unaffected by the presence of SOD, suggesting a direct electron transfer reaction (Fig.1d) . CybB can thus react with both superoxide and ubiquinol, via two separate mechanisms.
Next we investigated if CybB catalyses electron transfer between its two substrates. When superoxide-reduced CybB was mixed with an excess of ubiquinone Q 2 , CybB was rapidly oxidized, indicating electron transfer from CybB to ubiquinone (Fig. 2a) . The reverse reaction, that is, CybB-catalysed superoxide production, was also observed when CybB was incubated with an excess of reduced ubiquinol Q 2 H 2 . This result shows that electron transfer can take place in either direction, consistent with enzymatic catalysis (Fig. 2b) . Considering the midpoint potentials of O 2 /superoxide (− 160 mV) 6 and ubiquinone/ubiquinol (+ 70 mV) 25 , these experiments strongly suggest that CybB is an enzyme that catalyses electron transfer from superoxide to ubiquinone, mediated by the two b hemes. This molecular mechanism was further supported by the results from multiple-turnover experiments in coupled enzyme assays, where superoxide release was monitored under various conditions ( Fig. 2c ) and superoxide production rates were calculated at different time points (Fig. 2d) . As expected, the HPX/XO data shows an almost linear increase in superoxide with time (Fig. 2c , experiment no. 2), and neither separate addition of ubiquinone Q 2 (experiment no. 3) nor purified CybB (experiment no. 4) affected superoxide production. However, if ubiquinone Q 2 and CybB were added together (experiment no. 6), initial superoxide production was almost completely abolished, but increased with time reaching ~100% of the HPX/XO activity after 3 min (Fig. 2c,d ). This suggests that the ubiquinone pool was fully reduced and that the electron acceptor substrate (oxidized ubiquinone) for CybB thus became rate-limiting. Indeed, when purified quinol bo 3 oxidase was added in order to regenerate the quinone pool, superoxide production was completely suppressed over the entire experiment (experiment no. 7; Fig. 2c,d ), and strictly dependent on the presence of CybB (experiment no. 5, Fig. 2c ). The requirement for bo 3 oxidase reinforces the role of ubiquinone as electron acceptor for CybB, as XO does not interact directly with quinone. The coupled enzymatic assay verified the suggested biochemical reaction sequence from the pre-steady-state experiments described above, and the results were consistent with a similar set of experiments using NADH/NDH-2 as the superoxide producer ( Supplementary Fig. 4 ).
The catalytic rate is in the diffusion-limited range. SODs are among the fastest enzymes known, with catalytic rates of the order of 10 8 -10 9 M −1 s −1 (ref.
26
). To measure the catalytic rate of detergent solubilized CybB, we applied a modified version of a published assay 27 . In this assay, the amount of either SOD, cytochrome c or CybB required to reduce the level of superoxide production by HPX/XO (assayed by WST-1) to 50% was determined by stepwise addition of the respective protein. Using the literature value for SOD (2 × 10 9 M −1 s −1 ), rate constants for cyt c and CybB were calculated as described previously 27 . The results show that CybB is an extremely fast enzyme with a second-order rate constant of 0.5-1.5 × , and thus in the diffusion-limited range (Supplementary Table 1 ). In contrast, the reaction with cytochrome c was about 100 to 500 times slower. These values can also be compared to other known adventitious reactions between metalloproteins and superoxide that have rate constants of the order of 10 4 -10 6 M −1 s −1 (ref. 6, 28 ).
CybB reacts with membrane-proximal superoxide. CybB was also functionally characterized in an artificial membrane system. Figure  2e shows the data from kinetic measurements in proteoliposomes and Fig. 2f shows a side-by-side comparison of experiments performed in proteoliposomes and in detergent micelles. Similar to the experiment in detergent micelles, reconstituted CybB mixed with NADH/NDH-2 was quickly reduced to ~50% in the presence, but not in the absence, of oxygen, indicating that superoxide was the reducing agent. Strikingly, SOD did not prevent reduction of CybB by NADH/NDH-2 in membranes (proteoliposomes), whereas it completely abolished the reaction in detergent micelles (see also Fig. 1c ). On the other hand, superoxide produced by HPX/XO was only able to marginally reduce membrane-reconstituted CybB, and this fractional reduction was completely abolished in the presence of SOD. The results suggest that superoxide produced in the aqueous environment (HPX/XO) cannot efficiently reach the membrane-embedded CybB. We speculate that electrostatic repulsion of the anionic membrane may contribute to this effect. In contrast, NDH-2 docks to the CybB-containing liposomes via its C-terminal helix 23 and produces superoxide at the membrane, which would allow it to efficiently reach the superoxide-binding site of CybB. The striking absence of an effect of SOD on the reaction between CybB and membrane-proximal superoxide suggests that CybB may intercept membrane-proximal superoxide before it reaches the aqueous compartment.
Molecular structure of CybB. The 1.97 Å crystal structure of CybB reveals a highly distorted integral membrane four-helix bundle. The protein is well-ordered and could be traced from residue 2 to 175 (out of 176) with the highest B-factors observed in the loop structures on the periplasmic side of the enzyme (the positive, P-side, of the membrane electrochemical gradient; Supplementary Fig. 5a and Supplementary Table 2 ). Calculation of the positioning of CybB 29 in the membrane suggests a 30 Å hydrophobic depth of insertion and a 23° insertion tilt angle. Two b-type heme groups are non-covalently bound in the core of the helical bundle, and one of the two hemes has the edge of the porphyrin ring exposed to the periplasm (Fig. 3a) . The iron ions of both heme groups are octahedrally coordinated by the porphyrin nitrogen atoms and two axial histidines, originating from helix 1 and 4 for heme 1 (cytoplasmic side, N-side) and helix 2 and 4 for heme 2. Consequently, the iron ions are hexacoordinate with no free coordination positions for exogenous ligands ( Supplementary Fig. 5c,d ). The closest distance between the conjugated heme edges in the protein is ~11 Å, a distance that predicts electron tunneling times in the microsecond to nanosecond range, which is also compatible with biochemical function 30, 31 . Near the cytoplasmic heme, an exogenous ligand is hydrogenbonded to the C-terminal metal-coordinating histidine of heme 1 (His151) and bound in a cavity delimited by helix 3, helix 4 and the heme porphyrin ring. This density is modeled as a glycerol molecule, derived from the crystallization solution, providing a good fit to the residual electron difference density (Fig. 3b) . The electrostatic potential of the protein surface on the P-side shows a pronounced positively charged funnel surrounding the exposed edge of heme 2 ( Fig. 3c and Supplementary Fig. 6 ). This design is strikingly analogous to active site surfaces observed in all SOD classes, where the electrostatic properties attract and guide the superoxide substrate to the catalytic redox-active site, thereby contributing to the very high catalytic rate of SODs 6, [32] [33] [34] . Based on the biochemical data, we hypothesize that ubiquinone binds in the membrane-exposed protein cavity near the cytosolmembrane interface. This presumption is supported by molecular docking calculations to the crystal structure (Fig. 3d) . To probe the ability of the ligand-binding pocket to recognize quinones, three representative head groups were seeded into a database of 4.6 million compounds. Based on the docking energy scores, ubiquinone displayed > 1000-fold enrichment over random selection ( Supplementary Figs. 7 and 8 ).
Three histidine residues and heme 1 contribute to the quinonebinding site and establish a protein channel encompassing a hydrogen-bonded solvent chain, which is potentially involved in proton uptake from the cytoplasm during quinone reduction (Fig. 3d,e) . A layer of hydrophobic amino acid sidechains is located between the hemes, preventing a hydrogen-bonded proton path through the protein (Fig. 3e) . The structural and electrochemical features suggest that the protein may be poised to transfer superoxide-derived electrons from the P-side of the enzyme whereas protons would probably be sequestered from the N-side aqueous compartment. Notably, this setup would be electrogenic, contributing to the electrochemical membrane potential while reducing the quinone pool in the process.
Gene regulation of CybB. The structure and function described above suggest a potential role of CybB in superoxide detoxification under oxidative stress. We therefore probed the expression pattern of CybB under different growth conditions. Quantitative reverse transcription PCR (RT-qPCR) was performed on total RNA extracted from E. coli cells sampled in the logarithmic and stationary phase, under both oxic and anoxic conditions. The results show that cybB messenger RNA levels are ~10-20-fold higher in the logarithmic phase than in the stationary phase ( Supplementary Fig. 9a ) and that this pattern is not influenced by the presence or absence of oxygen. This is intriguing, as production of superoxide is expected to be considerably lower or nonexisting during anoxic metabolism. However, it is known that other ROS scavenging enzymes, including E. coli FeSOD, are also produced under anaerobic conditions, possibly as a safeguard for oxygen exposure 28, 35 .
Superoxide production of inverted membrane vesicles. Using WST-1 as indicator and NADH as electron source, we further measured the superoxide production of respiring membrane vesicles isolated from cybB-knockout and CybB-overproducing E. coli cells, as well as control cells (expressing wild-type levels of CybB). The superoxide numbers were normalized for NADH oxidation. Even though we could not detect a difference between the knockout and the control cells ( Supplementary Fig. 9b ), a substantial reduction of superoxide detection was observed in membranes from cells overexpressing CybB (Supplementary Fig. 9c ). The absence of an effect in the former case is probably due to the experimental setup, in which the much higher concentration of the amphiphilic superoxide indicator WST-1 competes with CybB and masks the activity of the endogenously expressed CybB. Rapid scavenging of membraneproduced superoxide by WST-1 is further corroborated by the observation that the presence of SOD does not reduce the detection of superoxide by WST-1 in either CybB-overexpressing or control membranes ( Supplementary Fig. 9c ). We note that this result and the results above also indicate the existence of a specific membraneassociated superoxide pool in slow equilibrium with soluble pools, as previously proposed for thylakoid membranes 18 . Such a superoxide pool could plausibly reach high effective local concentrations in this essentially two-dimensional compartment, and possibly be out of reach for globular SOD enzymes.
The CybB protein family. Phylogenetically, E. coli CybB belongs to the NCBI cl23723 Cytochrome_b_N superfamily, and specifically to the COG3038 (Cytochrome b 561 ) and PRK11513 protein families, comprising proteins from important human pathogens, for example Pseudomonas aeruginosa, Salmonella enterica, Shigella dysenteriae, Vibrio cholera and Yersinia pestis (Supplementary Fig. 10 ). A number of other Cytochrome_b_N protein families also display the same transmembrane helix topology and similar sequence conservation patterns, including the heme-coordinating histidine residues and residues presumably involved in proton transfer to the quinone. Many organisms encode several CybB homologs, for example three each in E. coli, P. aeruginosa, S. enterica and Y. pestis (Supplementary Fig. 10 ). The functions of these homologs are presently unknown. Further biochemical and bioinformatic studies are required to define and characterize this enzyme family.
Discussion
Redox proteins are notoriously promiscuous and require substantial effort to unambiguously determine their primary biochemical substrate or function. For CybB, ubiquinol and superoxide (but not hydrogen peroxide) displayed a fast reactivity, suggesting electron transfer from superoxide to ubiquinone. The measurement of the catalytic rate constant of CybB (~1 × 10 8 M −1 s −1
) indicates that the reaction is in the diffusion-limited range. CybB is thus what is commonly denoted a "kinetically perfect" enzyme for superoxide oxidation and it appears extremely unlikely that such an efficient enzymatic design would occur by accident. We therefore hypothesize that CybB has evolved to quench superoxide, and propose that this family of superoxide-scavenging enzymes be denoted superoxide oxidase (SOO).
The respiratory chain is a major source of superoxide 28 . It has been shown that approximately 25% of all superoxide is generated by membranes 6 and that E. coli produces considerable amounts of periplasmic superoxide during exponential growth, largely due to NDH-2 activity and menaquinone auto-oxidation in the membrane 19 . Interestingly, however, periplasmic SOD is synthesized only when cells enter stationary phase 19, 36 . An attractive possibility is that periplasmic SOD is expressed primarily as protection against external superoxide, whereas the primary function of CybB may be to quench membranous superoxide close to its site of production (for example, the respiratory enzymes in the membrane). In line with this reasoning, cybB mRNA levels showed the opposite pattern to that of periplasmic SOD, being > 20 higher during the logarithmic compared to the stationary phase.
Electron leakage resulting in superoxide formation is a threat to the organism and also results in electron transfer to O 2 without conservation of energy. In this study, we have functionally and structurally characterized a protein that potentially alleviates both of these problems. The architecture of SOO suggests electrogenic quenching of membrane-proximal superoxide by obtaining the electron from superoxide produced at, or within, the membrane and sequestering protons from the N-side, thereby creating a net charge separation while conserving energy by reducing the quinone pool in the process. A hypothetical biochemical context of SOO is depicted in Fig. 4 . Important future directions are to study the membraneassociated superoxide pool and the SOO mechanism in detail, as well as to establish the physiological function of the enzyme and determine if there are functional homologs of SOO in eukaryotic cells. In this context, it is interesting to note that there is a eukaryotic membrane protein family, eukaryotic Cyt b 561 , annotated as ascorbate-and iron-dependent oxidoreductases 37 . A recently solved crystal structure of this protein from Arabidopsis thaliana shows that it has a different topology and no quinone-binding site. However, it displays an analogous heme architecture and contains a positively charged patch with an exposed heme edge. It may thus be well worth testing proteins of this eukaryotic family for their reactivity with superoxide.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0072-x. 
Plasmids and expression. The expression plasmid pCybB-His was engineered from a GFP-tagged E. coli CybB construct by replacing the GFP moiety with a 8× Histag, as described previously 38 . The new construct was transformed into chemically competent T7 express lysY (New England Biolabs) and grown at 37 °C, either in LB medium supplemented with 25 mg l -1 kanamycin and 0.01% Antifoam 204 (for non-Se-Met labeled CybB) or in minimal media supplemented with 0.4% glucose, 2 mM MgSO 4 , 0.1 mM CaCl 2 , 1 μ M MnCl 2 , 10 μ M FeSO 4 , 25 mg l -1 kanamycin and 0.01% Antifoam 204 (for production of selenomethionine labeled protein for structural determination). At culture absorbance A 600 nm ~0.7, the minimal media cultures were supplemented with a mixture of amino acids (100 mg l -1 lysine, 100 mg l -1 threonine, 100 mg l -1 phenylalanine 50 mg l -1 leucine, 50 mg l -1 isoleucine, 50 mg l -1 valine and 50 mg l -1 selenomethionine). Expression of CybB and CybB SeMet was induced by the addition of 0.2 mM IPTG, and the culture was grown for four more hours. The cells were harvested by centrifugation at 7,500g in a JLA 8.1000 rotor (Beckman Coulter), transferred to 50 ml tubes and frozen at − 20 °C.
Membrane preparation. Membrane preparation and protein purification were performed using the same procedures for both SeMet-labeled and unlabeled protein. The frozen CybB/CybB SeMet cell pellet was thawed, resuspended in lysis buffer (50 mM phosphate buffer pH 7.0, 200 mM NaCl, 5% glycerol, 1 mg ml -1 lysozyme, 20 μ g ml -1 DNase, EDTA-free cocktail protease inhibitors (Roche)) and lysed in an Emulsiflex C3 system (Avestin Inc.) or in a Maximator HPL6 (Maximator AG, Switzerland). All lysis and membrane preparation steps were performed at 4 °C. The lysate was cleared by 30 min centrifugation at 20,000g in a Beckman JA 25.50 rotor. The supernatant was transferred to a Beckman Ti45 ultracentrifuge rotor and centrifuged at 40,000 r.p.m. for 1 h. The membrane pellet was resuspended in membrane wash buffer (50 mM phosphate buffer pH 7.0, 200 mM NaCl, 5% glycerol). After a second round of ultracentrifugation, the washed and resuspended membranes were aliquoted and flash-frozen in liquid nitrogen.
Protein purification. Membranes were thawed and solubilized in 1% octyl glucose neopentyl glycol (OGNG) (Anatrace) for 2 h. Insoluble material was cleared by ultracentrifugation for 30 min at 40,000 r.p.m. in a Beckman Ti70.1 rotor. The supernatant was incubated at 4 °C with Ni 2+ -charged Profinity (BioRad) IMAC resin for 2 h with gentle rotation (5 mM Imidazole was added after 1 h of incubation). The sample was loaded on a Econo-Pac disposable gravity flow column (Bio-Rad). The settled resin was washed with 15 column volume (CV) IMAC wash buffer 1 (10 mM HEPES pH 7.0, 200 mM NaCl, 50 mM Imidazole, 5% glycerol, 0.1% OGNG) and 15 CV wash buffer 2 (10 mM HEPES pH 7.0, 200 mM NaCl, 5% glycerol, 0.1% OGNG). CybB/CybB SeMet was eluted with 3 × 0.75 CV elution buffer (10 mM HEPES pH 7.0, 200 mM NaCl, 100 mM EDTA, 5% glycerol, 0.1% OGNG), concentrated to 0.5 ml using Vivaspin concentration devices with 50 kD cutoff (Sartorius) and subjected to size exclusion chromatography (10 mM HEPES pH 7.0, 200 mM NaCl, 5% glycerol, 0.1% OGNG) on a 30 ml BIOSEP-SEC-S3000 column (Phenomenex) connected to a Shimadzu Prominence HPLC system. Fractions representing the CybB/CybB SeMet peak were pooled, concentrated to 10-12 mg ml -1 (CybB) and 11 mg ml -1 (CybB SeMet ) with 50 kDa concentrator cutoff, and flash-frozen in liquid nitrogen.
Chemicals for functional experiments. Lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA). WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) was purchased from Dojindo Molecular Technologies. All other chemicals were purchased either from Sigma Aldrich or Santa Cruz Biotechnology.
Reduction of ubiquinone Q 2 . Ubiquinone Q 2 was pre-reduced by addition of a few grains of sodium borohydride to a solution of 50 µ M Q 2 (dissolved in anhydrous EtOH). Reduction was carried out for 20 min on ice and quenched by addition of 2 µ l of 36% HCl (aqueous). Residual sodium borohydride was removed by centrifugation at 20,000g for 5 min for at least three times. Reduced ubiquinol Q 2 H 2 was stored in aliquots at − 20 °C.
Preparation of liposomes.
E. coli polar extract was dissolved in chloroform at 20 mg ml -1 and 250 µ l of the solution was mixed in a 25 ml round-bottom flask. Chloroform was evaporated under a constant N 2 stream, and the lipid film was further dried for 4-12 h in a desiccator and resuspended at 5 mg ml -1 in 20 mM HEPES, pH 7.4, 20 mM KCl and 200 mM NaCl. Unilamellar liposomes were formed by seven freeze-thaw cycles and down-sized using a Vibra-cell VCX 130 probe sonicator (Sonics & Materials) at a frequency of 9 kHz for 2.5 min (30 on, 30 off) on ice. Liposomes were kept on ice until protein reconstitution.
Reconstitution of CybB into liposomes.
Reconstitution of CybB was performed as described earlier for other membrane proteins 39 . Briefly, 20 µ l of 500 µ M purified CybB was mixed with 250 µ l sonicated liposomes (5 mg ml -1 ) and 0.6% (w/v) sodium cholate and incubated for 30 min at room temperature. Detergent was removed by passing the suspension over a PD-10 gel filtration column (GE Healthcare). The final concentration of CybB in liposomes was 10 µ M. Proteoliposomes were kept at 4 °C and used the same day for measurements. In a first set of experiments, 1 µ M purified CybB in 0.5 ml assay buffer (20 mM HEPES, pH 7.4, 20 mM KCl, 200 mM NaCl, 0.05% (w/v) n-Dodecyl-β -D-Maltopyranoside (DDM)) was mixed with different biological reductants such as 1 mM ascorbate, 1 mM succinate, 1 mM reduced glutathione (GSH), 1 mM NADH, 40 µ M hydrogen peroxide (H 2 O 2 ), or a mixture of 0.1 mM ubiquinone Q 2 and 1 mM dithiothreitol (DTT). Alternatively, 0.2 µ M purified E. coli type-II NADH:quinone oxidoreductase (NDH-2) together with 0.1 mM NADH were added. Spectra were monitored after 2 min of incubation between 400 nm and 600 nm. Reduction of 1 µ M CybB by 7.6 mU ml -1 XO was measured in 100 mM sodium phosphate, pH 8.0, 0.1 mM diethylenetriaminepentaacetic acid (DETAPAC), 0.1 mM HPX and 0.05% (w/v) DDM. ROS-mediated reduction of CybB was investigated by addition of 30 U ml -1 SOD or 6 U ml -1 catalase to the solutions described above. Anaerobic conditions were achieved by addition of 5 mM glucose, 60 U catalase and 2.5 U glucose oxidase after 1 min. Measurements with reconstituted CybB were done with 0.1 ml (5 mg ml -1 ) proteoliposomes containing 10 µ M CybB in 0.9 ml 20 mM HEPES, pH 7.4, 20 mM KCl and 200 mM NaCl. Reduction of b-type hemes of CybB by different reductants was normalized to full reduction achieved by addition of 50 mM sodium dithionite. All experiments were performed at 25 °C with two separate purifications of CybB in duplicates.
Reduction of
Stopped-flow kinetics. Reduction of CybB by NADH/NDH-2 and pre-reduced ubiquinol Q 2 H 2 was resolved by stopped-flow kinetics using a RX2000 Rapid Kinetics Spectrometer Accessory Unit (Applied Photophysics) with a dead time of 8 ms. One syringe was filled with a solution of 1 µ M CybB in assay buffer and the other one with either a solution of 125 µ M Q 2 H 2 or 200 µ M NADH + 0.2 µ M NDH-2. Shown are averaged data points from three separate measurements.
Determination of rate constants. The rate constants of detergent solubilized CybB were determined with the method described by Flint et al. 27 with the following modifications. Superoxide production by HPX/XO was followed using the reduction of WST-1 at 455 nm in a buffer containing 100 mM sodium phosphate, pH 8.0 buffer containing 0.2 mM WST-1, 0.1 mM DETAPAC, 0.1 mM HPX, 0.05% (w/v) DDM, 6 U ml -1 catalase, 64 nM bo 3 oxidase and 0.1 mM Q 2 . Subsequently, SOD was added stepwise until superoxide production was decreased to ~50%. This procedure was repeated in the same buffer with additions of either cytochrome c or CybB. Using the literature value of the SOD rate constant and the respective concentrations of enzymes used to reduce superoxide production to 50%, the rate constants of cytochrome c and CybB were calculated according to Flint et al. 27 and Klug et al. 40 . Experiments were performed in triplicates with two different CybB purifications.
Preparation of E.coli inverted membrane vesicles. Overexpression of CybB in E. coli BL21/pLysS cells was achieved as described above. E. coli strains BL21/ pLysS and BW25113 containing the wild-type cybB gene and the cybB KO strain (Keio designation: JW5224-1 41 ) were grown in M9 minimal medium containing 2% (w/v) glucose into the exponential phase (A = 0.5-0.7) at 37 °C, 200 r.p.m. Cells were collected by centrifugation (5,000g, 4 °C 15 min), washed in 20 mM HEPES, pH 7.4, 20 mM KCl and 200 mM NaCl, and resuspended in the same buffer in the presence of 1 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride and DNaseI. The solution was stirred for 20 min at 4 °C and passed twice through a Maximator HPL6 (Maximator AG) yielding inside-out membrane vesicles 42 . Unbroken cells were removed by low-spin centrifugation (7,500g, 20 min, 4 °C) and membrane vesicles were washed twice in 20 mM HEPES, pH 7.4, 20 mM KCl, 200 mM NaCl by ultracentrifugation (150,000g, 4 °C, 1 h).
Purification of bo 3 ubiquinol oxidase and NADH:quinone oxidoreductase NDH-2. Purification of E. coli bo 3 ubiquinol oxidase and NADH:quinone oxidoreductase NDH-2 was performed as described 43, 44 .
Superoxide assay. Production of superoxides was detected by monitoring the superoxide-mediated reduction of a tetrazolium dye (WST-1) as described by Peskin and Winterbourn 45 . Briefly, reduction of WST-1 was monitored at 455 nm in assay buffer, 20 mM HEPES, pH 7.4, 20 mM KCl, 200 mM NaCl containing 20 µ g ml -1 catalase and 50 µ M WST-1. NADH oxidation of inside-out membrane vesicles from E. coli strains were adjusted to the same oxidation rates before measuring superoxide production. Measurements with 200 nM purified CybB were done in assay buffer containing 0.05% DDM and one or several of the following additives: 200 µ M NADH, 100 µ M Q 2 , 2 nM NDH-2 and/or 60 nM bo3 oxidase. In another series of measurements, XO (7.6 mU ml -1 ) instead of NDH-2 was used. The measuring buffer was 100 mM sodium phosphate, pH 8.0, 0.1 mM diethylenetriaminepentaacetic acid, 0.1 mM HPX and 0.05% (w/v) DDM.
Bacteria strain and growth conditions for gene regulation experiments. E. coli BW25113 strain (parental strain of the Keio collection 41 ) was used for gene regulation experiments. As control, a cybB knockout strain (Keio designation: JW5224-1) was included. A few colonies were picked from agar plates, inoculated into 5 ml LB medium and incubated at 37 °C overnight. Cells from the overnight grown culture were harvested by centrifugation (5,000g, 4 °C, 10 min), washed twice with PBS and resuspended in 5 ml PBS. 200 µ l of the resuspended cells were used to inoculate 20 ml M9 minimal medium containing 2% (w/v) glucose as a carbon source. Cell cultures were grown at 37 °C, 200 r.p.m. and sampling was done using half of the culture either in the mid-log phase at A between 0.5 and 0.7 or in the stationary phase after overnight incubation. Cells were harvested by centrifugation (8,000g, 25 °C, 2 min), and the pellet was directly used for RNA extraction. Anaerobic conditions were achieved using basic 1,2,3-trihydroxybenzene (pyrogallol). Briefly, 10 ml minimal medium were poured into a test tube (14 mm inner diameter × 160 mm tall) and the medium was covered with two layers of cotton wool. To the upper layer 200 µ l of saturated sodium carbonate and 200 µ l of 20% (w/v) pyrogallol was added dropwise and the test tube was sealed with a rubber plug and wrapped with several layers of Parafilm M. To test anaerobicity, E. coli BW25113 cells were inoculated in minimal medium containing 2% (w/v) succinate as a nonfermentable carbon source at 37 °C, 200 r.p.m., allowing growth by oxidative phosphorylation only. No increase in A was detected over 60 h of incubation.
RNA extraction. Total RNA was extracted as described with minor modifications 46 . Cell pellets were resuspended in 600 µ l 100 mM Tris, pH 7.5, 10 mM EDTA, 1 M NaCl. Next, 600 µ l pre-heated (65 °C) water-saturated acidic phenol (pH < 7) containing 1% (w/v) SDS was immediately added and cells were lysed for 5 min at 65 °C. The lysed cells were frozen in liquid N 2 and stored at -20 °C until RNA extraction.
Frozen cell extracts were thawed at 65 °C and centrifuged (17,000g, 4 °C, 10 min). The aqueous phase was transferred to a new tube containing an equal volume of 1:1 acidic phenol:chloroform, mixed vigorously and centrifuged again. The upper phase was transferred to a new tube containing the same volume of chloroform, mixed and centrifuged again. The upper phase was mixed with 700 µ l ice-cold 2-propanol and incubated for 2 h at − 20 °C, followed by centrifugation. The RNA pellet was washed twice with 75% (v/v) ice-cold ethanol, vacuum dried for 10 min and resuspended in 50 µ l DEPC-treated water. RNA extraction was performed from two independent growth studies.
Complementary DNA synthesis and RT-qPCR. In general, 2.5 µ g total RNA was used for DNA digestion and reverse transcription. DNA was removed using TURBO DNase kit (Ambion) according to the protocol of the manufacturer. Real-time RT-qPCR was performed as described 47 . Published primer pairs of two different housekeeping genes (idnT and hcaT), which show stable expression in many different growth conditions, were used for normalization 48 . Amplification of a 162 bp fragment of cybB was performed using CGCAGCGTAT TGCGCAATGG AGTTTCG as forward and GGCTTAGGTA TAATCGGCGGG GTTGGG as a reverse primer. As a control cDNA from a cybB knockout strain was included. cybB mRNA levels were measured in triplicates by RT-qPCR and normalized to the mRNA levels of idnT. The mRNA levels of cybB in the exponential phase under aerobic conditions were defined as 100%.
Crystallization. Frozen CybB-His SeMet protein was thawed on ice and 1 mM TCEP was added. Crystallizations were set up manually in sitting drops under silicon oil (octamethyltrisiloxane, Sigma-Aldrich). A 48-well MRC Maxi crystallization plate (Molecular Dimensions) was coated with EGC-1700 (3 M Science) and 0.75 μ l protein and 0.25 μ l well solution was added to a 4 μ l silicone drop. Red, rod-shaped, rhombic cross section crystals appeared overnight in: 200 mM HEPES pH 7.5; 5% glycerol; 25% PEG 2000 MME; 50 mM MgCl 2 . Crystals were grown for 5 days at 20 °C, and were picked straight from the drop, without additional cryoprotectant, and flash-frozen in liquid nitrogen.
Data collection and processing. Data collection was performed at beam line X06SA (PX-I) at the Swiss Light Source, Paul Scherrer Institute, Switzerland. Data were collected at the Selenium edge (0.9797 Å; 12,655 keV) using a Pilatus 6 M detector. The dataset (Supplementary Table 1 ) was collected from the largest obtained crystal (~0.1 × 0.1 × 0.2 mm 3 ). A 360° dataset was collected at 100 K, with an image width of 1°. The dataset was integrated and scaled using the X-ray Detector Software package (XDS) 49 , and the full set of 360 images was used to gain initial phase estimates by SAD, using HKL2MAP 50 . The protein sequence contains 11 methionine residues; 10 significant anomalous peaks were identified in the data and used for phasing.
Model building and refinement. Phenix Autosol 51 was used to build an initial model. A second dataset was generated by integrating the data while merging the Friedel pairs. This dataset was used for subsequent manual model building with COOT 52 and refinement with Refmac5
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. A few distinct volumes of experimentally determined density on the protein surface could not be accurately modeled. These presumably represent buffer molecules, ordered parts of detergent tails or (native) lipid molecules carried along through protein purification. The model refined with good stereochemistry and a Ramachandran plot distribution of 99% favored, 1% allowed and 0% outliers. The structure and crystallographic data have been deposited in the Protein Data Bank (PDB) with code 5OC0.
Crystal structure figures. Crystal structure figures were prepared using PyMol (The PyMOL Molecular Graphics System) Electrostatic surfaces were calculated including all cofactors using the Adaptive Poisson-Boltzmann Solver (APBS) 54 and visualized using the APBS plugin in PyMol.
Docking. Molecular docking of ubiquinone, menaquinone and demethylmenaquinone as well as a database of commercially available compounds to the crystal structure were performed with DOCK3.6 (http://dock.compbio. ucsf.edu/) using a physics-based scoring function [55] [56] [57] . Ionizable residues Asp, Glu, Arg and Lys were set to their most probable state at pH 7. Protonation states for histidines were based on analysis of hydrogen bonding network. Binding site residues H87, H151 and H158 were protonated at the Nε , Nδ and both nitrogen positions, respectively. All compounds were docked to a rigid receptor structure using a flexible ligand sampling algorithm 57 . DOCK3.6 superimposes atoms of the docked molecule onto binding site matching spheres, which indicate putative ligand atom positions. Forty-five matching spheres were used to define the binding site and these were based on the binding mode of the menaquinone analog in the crystal structures of formate dehydrogenase-N (PDB code: 1KQG) 58 . The ligand sampling parameters bin size, bin size overlap and distance tolerance were set to 0.8 Å, 0.1 Å and 1.5 Å, respectively, for both the matching spheres and docked molecules. For each docked compound that passed an initial steric filer, binding energies were calculated from pre-generated grids as the sum of the receptorligand electrostatic and van der Waals interaction energy, corrected for compound desolvation 56 . AMBER force field parameters 59 were used for all protein atoms except His151, for which the side chain dipole moment was increased to favor interactions with this residue. The heme group with Fe 2+ was modeled based on parameters described previously 60 . As the docked compounds were expected to become fully desolvated by the protein and membrane environment, the full desolvation setting was used. Energy minimization of 50 steps was performed for the best scoring conformation of each compound. Only the headgroup of the quinones (Supplementary Fig. 7 ) were docked to the binding site as the hydrophobic tail is likely to extend into the membrane, which was not explicitly modeled. The lead-like screening library of 4.6 million commercially available compounds was retrieved from the ZINC database 56 . All compounds were prepared for docking using the ZINC database protocol. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were chosen based on previous literature in the field. At least three different protein preparations were used for statistical measurements.
Data exclusions
Describe any data exclusions.
No data was excluded
Replication
Describe whether the experimental findings were reliably reproduced.
Experimental findings were reliably reproduced
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples and conditions were not randomized, only the wild type variant of the protein was used
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not used in this study
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
